title: Intraperitoneal hyperthermic perfusion (IPHP).
abstract: Intraperitoneal hyperthermic perfusion (IPHP) with a solution that contains CDDP (25 mg/m(2)/l) and MMC (3.3 mg/m(2)/l) was clinically introduced in the treatment of peritoneal carcinomatosis. Twenty-six patients underwent surgical treatment and IPHP. Peritoneal carcinomatosis was classified at laparotomy using the Japanese classification: P1 (n=3), P2 (n=5), P3 (n=15), unclassifiable (n=3). In this series of patients only the creatinine and amylase values were significant in biological toxicity evaluation. The surgical complication rate (2 duodenal fistulas) does not differ from the general extensive abdominal surgery.
authors: IST NAZL STUDIO & CURA TUMORI,ANAESTHESIOL & INTENS CARE UNIT,I-20133 MILAN,ITALY. IST NAZL STUDIO & CURA TUMORI,DIV GYNAECOL ONCOL,I-20133 MILAN,ITALY.
authors: M
authors: M
authors: Deraco
authors: M
authors: M
authors: Vaglini
authors: M
authors: M
authors: Santinami
authors: N
authors: N
authors: Santoro
authors: M
authors: M
authors: Inglese
authors: G
authors: G
authors: Spatti